Clinical Trial Update: Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain [NA]

View source ↗

Summary

Bevacizumab is being studied as neoadjuvant therapy for new high-grade gliomas in the brain; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Glioma
• High-grade Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Brain Glioma | NA | Status: RECRUITING